feed,title,long_url,short_url
MedRxiv,"Phase 1 Study of Safety, Reactogenicity, and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate Administered as Inhalation Boost in SARS-CoV-2 Immunized Adults",https://medrxiv.org/cgi/content/short/2025.10.07.25337492v1?rss=1,
MedRxiv,Evaluating Rural/Urban HPV Vaccine Completion Rates in Iowa After the COVID-19 Pandemic,https://medrxiv.org/cgi/content/short/2025.10.07.25337497v1?rss=1,
MedRxiv,First-in-Human Study of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix,https://medrxiv.org/cgi/content/short/2025.10.07.25337449v1?rss=1,
